72 related articles for article (PubMed ID: 29140513)
1. Amino Acid and Fatty Acid Levels Affect Hepatic Phosphorus Metabolite Content in Metabolically Healthy Humans.
Kahl S; Nowotny B; Strassburger K; Bierwagen A; Klüppelholz B; Hoffmann B; Giani G; Nowotny PJ; Wallscheid F; Hatziagelaki E; Pacini G; Hwang JH; Roden M
J Clin Endocrinol Metab; 2018 Feb; 103(2):460-468. PubMed ID: 29140513
[TBL] [Abstract][Full Text] [Related]
2. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients.
Fritsch M; Koliaki C; Livingstone R; Phielix E; Bierwagen A; Meisinger M; Jelenik T; Strassburger K; Zimmermann S; Brockmann K; Wolff C; Hwang JH; Szendroedi J; Roden M
Am J Clin Nutr; 2015 Nov; 102(5):1051-8. PubMed ID: 26423389
[TBL] [Abstract][Full Text] [Related]
3. Abnormal hepatic energy homeostasis in type 2 diabetes.
Szendroedi J; Chmelik M; Schmid AI; Nowotny P; Brehm A; Krssak M; Moser E; Roden M
Hepatology; 2009 Oct; 50(4):1079-86. PubMed ID: 19637187
[TBL] [Abstract][Full Text] [Related]
4. Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes.
Gancheva S; Bierwagen A; Kaul K; Herder C; Nowotny P; Kahl S; Giani G; Klueppelholz B; Knebel B; Begovatz P; Strassburger K; Al-Hasani H; Lundbom J; Szendroedi J; Roden M;
Diabetes; 2016 Jul; 65(7):1849-57. PubMed ID: 27207512
[TBL] [Abstract][Full Text] [Related]
5. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus.
Kupriyanova Y; Zaharia OP; Bobrov P; Karusheva Y; Burkart V; Szendroedi J; Hwang JH; Roden M;
J Hepatol; 2021 May; 74(5):1028-1037. PubMed ID: 33259845
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
[TBL] [Abstract][Full Text] [Related]
7. Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using
Pfleger L; Gajdošík M; Wolf P; Smajis S; Fellinger P; Kuehne A; Krumpolec P; Trattnig S; Winhofer Y; Krebs M; Krššák M; Chmelík M
J Magn Reson Imaging; 2019 Feb; 49(2):597-607. PubMed ID: 30291654
[TBL] [Abstract][Full Text] [Related]
8. Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos
Gancheva S; Bierwagen A; Markgraf DF; Bönhof GJ; Murphy KG; Hatziagelaki E; Lundbom J; Ziegler D; Roden M
Mol Metab; 2018 Jan; 7():71-79. PubMed ID: 29122559
[TBL] [Abstract][Full Text] [Related]
9. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.
Llauradó G; Sevastianova K; Sädevirta S; Hakkarainen A; Lundbom N; Orho-Melander M; Groop PH; Forsblom C; Yki-Järvinen H
J Clin Endocrinol Metab; 2015 Feb; 100(2):607-16. PubMed ID: 25405502
[TBL] [Abstract][Full Text] [Related]
10. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
12. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
13. Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers.
Freyse EJ; Giessmann T; Petzke KJ; Knospe S; Engel G; Heinke P; Metges CC; Siegmund W
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E54-62. PubMed ID: 12791602
[TBL] [Abstract][Full Text] [Related]
14. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
15. Targeted metabolomic analysis reveals the association between the postprandial change in palmitic acid, branched-chain amino acids and insulin resistance in young obese subjects.
Liu L; Feng R; Guo F; Li Y; Jiao J; Sun C
Diabetes Res Clin Pract; 2015 Apr; 108(1):84-93. PubMed ID: 25700627
[TBL] [Abstract][Full Text] [Related]
16. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance.
Viljanen AP; Iozzo P; Borra R; Kankaanpää M; Karmi A; Lautamäki R; Järvisalo M; Parkkola R; Rönnemaa T; Guiducci L; Lehtimäki T; Raitakari OT; Mari A; Nuutila P
J Clin Endocrinol Metab; 2009 Jan; 94(1):50-5. PubMed ID: 18957499
[TBL] [Abstract][Full Text] [Related]
17. The association of desaturase 9 and plasma fatty acid composition with insulin resistance-associated factors in female adolescents.
Zhou YE; Egeland GM; Meltzer SJ; Kubow S
Metabolism; 2009 Feb; 58(2):158-66. PubMed ID: 19154947
[TBL] [Abstract][Full Text] [Related]
18. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
19. Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes.
Knebel B; Strassburger K; Szendroedi J; Kotzka J; Scheer M; Nowotny B; Müssig K; Lehr S; Pacini G; Finner H; Klüppelholz B; Giani G; Al-Hasani H; Roden M;
J Clin Endocrinol Metab; 2016 May; 101(5):2130-40. PubMed ID: 26829444
[TBL] [Abstract][Full Text] [Related]
20. Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men.
Poynten AM; Gan SK; Kriketos AD; Campbell LV; Chisholm DJ
J Clin Endocrinol Metab; 2005 Feb; 90(2):1035-40. PubMed ID: 15562033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
